LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 7 of 15: Mean cell count and mean growth rate across all replicates. - Dataset (ID:20243)

Filter results: >>>>
  • Page 1 of 166
  • 1 to 25 of 4140 records
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit LJP Library Plate Mean Relative Cell Count Standard Error of the Mean for Relative Cell Count Mean Relative Growth Rate Standard Error of the Mean for Relative Growth Rate
BT-20 Enzastaurin
10.0
uM
LJP5
1.1895 0.0305 1.2746 0.0438
Hs 578T SB590885
0.04
uM
LJP5
1.1873 0.0255 1.2483 0.0422
Hs 578T Sorafenib
1.11
uM
LJP6
1.1702 0.0722 1.2312 0.1010
Hs 578T SB590885
3.33
uM
LJP5
1.1567 0.0721 1.2128 0.0987
Hs 578T SB590885
0.12
uM
LJP5
1.1559 0.0303 1.2073 0.0457
Hs 578T Sorafenib
0.37
uM
LJP6
1.1546 0.0561 1.2089 0.0793
Hs 578T SB590885
1.11
uM
LJP5
1.1546 0.0559 1.2085 0.0785
SK-BR-3 XL147
1.11
uM
LJP5
1.1502 0.0432 1.2445 0.0668
Hs 578T SB590885
0.37
uM
LJP5
1.1414 0.0454 1.1898 0.0638
Hs 578T Sorafenib
3.33
uM
LJP6
1.1411 0.0654 1.1919 0.0899
BT-20 Enzastaurin
3.33
uM
LJP5
1.1387 0.0317 1.1998 0.0437
Hs 578T PLX-4720
0.37
uM
LJP5
1.1380 0.0391 1.1841 0.0548
MCF7 XL147
0.04
uM
LJP5
1.1357 0.0272 1.1872 0.0348
Hs 578T Sorafenib
0.12
uM
LJP6
1.1350 0.0310 1.1806 0.0475
MCF7 SU11274
0.04
uM
LJP5
1.1342 0.0227 1.1866 0.0328
SK-BR-3 XL147
3.33
uM
LJP5
1.1328 0.0271 1.2180 0.0407
SK-BR-3 CP466722
0.04
uM
LJP5
1.1311 0.0127 1.2161 0.0090
SK-BR-3 Nilotinib
0.37
uM
LJP5
1.1290 0.0113 1.2149 0.0225
Hs 578T PLX-4720
1.11
uM
LJP5
1.1271 0.0570 1.1724 0.0779
SK-BR-3 SB590885
1.11
uM
LJP5
1.1253 0.0129 1.2083 0.0227
SK-BR-3 SB590885
0.37
uM
LJP5
1.1244 0.0097 1.2080 0.0225
SK-BR-3 SB590885
0.04
uM
LJP5
1.1238 0.0082 1.2055 0.0133
SK-BR-3 XL147
0.12
uM
LJP5
1.1229 0.0326 1.2002 0.0495
SK-BR-3 SU11274
0.04
uM
LJP5
1.1201 0.0316 1.2033 0.0567
MCF7 CP466722
0.04
uM
LJP5
1.1188 0.0260 1.1653 0.0378
  • Page 1 of 166
  • 1 to 25 of 4140 records